chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st day after vaccines, increased R leg pain and L upper extremity pain and swelling. Purpura on thighs and trunk. Unable to bear weight on R leg. Admitted and treated for IV fluids and pain management. Improved overnight. Labs unremarkable and was discharged the next day. 4 days after vaccination child returned with polymigratory arthritis, palpable purpura, and 1+ protein in urine. Suspect Henoch Schonlein purpura. Currently still admitted for pain management.
Pt recv vax on 11/16/98; on 11/17/98 pt exp red mottled/bumpy rash on arms, legs
Arm hurt for a day and a half; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt for a day and a half) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurt for a day and a half). At the time of the report, VACCINATION SITE PAIN (Arm hurt for a day and a half) outcome was unknown.            No Concomitant medication reported. Patient was vaccinated in left arm for first dose and vaccinated in right are for second dose. No treatment medication reported.
No ADR, was given boosters too close together - administered 3/1/22 and again 4/22/22
Initial report was received from a consumer, who was also the patient, on 19 May 2012. A 68-year-old male patient had received an injection of ADACEL (lot number, route and site not reported) on 17 May 2012. Since the vaccination, the patient has felt very tired. On 19 May 2012, the patient experienced "heart palpitations", will have feeling of 3 beats and stop and then 3 beats and stop. The patient also felt hot and had swollen glands of the throat. The patient had not yet contacted a health care professional (HCP). The patient had no illness at the time of vaccination. Medical history was not reported. The patient's outcome was unknown. Documents held by sender: None.
a root canal done tomorrow.; This is a spontaneous report from a contactable male consumer (the patient) via the  sponsored program.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number unknown), via an unspecified route of administration on an unspecified date for COVID-19 vaccination. Medical history was not reported. Concomitant medications not were reported. The patient stated that he is supposed to get his second dose on Friday but is having a root canal done tomorrow. Clarified if the root canal was scheduled prior to the first dose and he said they haven't scheduled it yet, they want to schedule for tomorrow, but are waiting to see if it would mess up his second dose of the COVID vaccine. The clinical outcome of dental disorder was unknown.     Information on the lot batch number has been requested.
Dizziness / Light headedness; Soreness at injection site; Itchy at injection site; Hardness at injection site / Thickness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness / Light headedness), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE INDURATION (Hardness at injection site / Thickness at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced DIZZINESS (Dizziness / Light headedness), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE INDURATION (Hardness at injection site / Thickness at injection site). At the time of the report, DIZZINESS (Dizziness / Light headedness), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE INDURATION (Hardness at injection site / Thickness at injection site) outcome was unknown.            No concomitant medications were reported. Treatment details included Ice.
No adverse effects reported.; a patient received an improperly stored dose of PROQUAD (lot S021325 exp 1/5/2021).; This spontaneous report was received from a medical assistant referring a patient of unknown age and gender. Information about pertinent medical history, drug reactions/allergies and concomitant therapies was not provided.    On 19-NOV-2019, multiple unknown patients received improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant Human albumin (rHA) (lot # S021325 and expiration date 05-JAN-2021; strength, dose, frequency and route were not reported) for prophylaxis (product storage error). No adverse effects were reported. The vaccine underwent temperature 17.2 Fahrenheit for a duration for 14 hours 30 minutes. There was no previous temperature excursion and data logger.
Received expired dose of the Moderna COVID19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna COVID19 vaccine) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059h21a) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired dose of the Moderna COVID19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reporter stated that the vial was initially stored in the refrigerator on 25-Mar-2022 and the vial did not undergo any temperature excursions. And the dose was patient's Booster dose.  No treatment medications were reported.
Felt flush in face; Headache; Achy; Tired; General feeling of being unwell.; Sore arm at the site of the injection.; This is a spontaneous report received from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included vitamin nos (DAILY MULTIVITAMIN), colecalciferol (VITAMIN D3) 5000 IU, all for unknown indication, for unknown period of time. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613 ), via an unspecified route of administration in the left arm on 19Mar2021, at 16:30 as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 14:30, the patient reported that she received second dose of the Pfizer BioNTech vaccine at 12 noon on 12Apr2021 and by 2:30 pm felt flush in her face, headache, achy, tired and general feeling of being unwell. She also experienced sore arm at the site of the injection. These symptoms continued on 12Apr2021 and 13Apr2021. On 14Apr2021 she felt better upon waking up. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events achy, tired, general feeling of being unwell, sore arm at the site of the injection were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
C/o instant headache and achiness at site since administration.  States pain is 8/10 on 11/23/09.  States feels like shoulder is dislocated.  "Want to cry with movement".  Swelling noted RAA.
11/26/21 presents to ED for " fevers for 1 week" "chills, cough, and myalgia". PMHx of "PE on Xarelto, HTN, DM, SLE, and Cardiomyopathy"
Pt received vaccine at 10:08 AM on 9/16/2020. On morning of 9/17/2020 pt felt weak, sat on commode while going to the bathroom, fell onto floor where he laid for 7 1/2 - 8 HRS until his wife got home and called ambulance. He was transported to Hospital where he was admitted for 5 days. Treated for pneumonia, cellulitis, sepsis & R/O MI. Released on 9/21/2020.
PERICARDITITIS THAT RESULTED IN ER VISIT AND CONSULTATION WITH CARDIOLOGIST. DID NOT RESULT IN HOSPITALIZATION.
606 doses were given after expiration date; Product storage error; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Product storage error). On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment medications were reported.  It was reported that there was a confusion between the expiration date printed in the carton and the expiration date when the code was scanned.  Patient had not experienced any adverse event and there was no temperature excursion
high swelling in her entire body; whole body has swells, like hives on it; really itchy; My whole body is covered in rash, like red; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 16Apr2021 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medication were not reported. Caller reported that she took the first dose of Pfizer COVID shot on last Friday, 16Apr2021. Caller stated that on Monday, 19Apr2021. she started getting really itchy and then all day Tuesday, 20Apr2021 through today, she experiencing high swelling in her entire body, her whole body has swells, like hives on it. In Apr2021, her whole body is covered in rash, like red was reported as worsened. Consumer stated right now she was taking Benadryl. Because it was an allergy medicine and her body covered in rash. It was a tablet she took last night from Walgreens, taking it for the rash. She just took it last night, orally. Caller would like to know are these side effects from the Pfizer COVID shot or should she go to the doctor. Patient was scheduled the second dose on Friday 07May2021. The outcome of whole body is covered in rash, like red was not recovered, of other events was unknown.   No follow up attempts are needed. No further information is expected.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.
Hard bump under skin at injection site, large red circle around injection site getting larger each day, itching, bumps, hot to the touch, started day after injection, and we are now 10 days post injection
Patient developed a large red, warm bump that was increasing with swelling and redness over the course of 4 days. Tried cold compress, tylenol
Temp of 101 1 day post immunization. Generalized tonic seizure 5 minutes. Post-ictal 1 hour.
As soon as shot was given, 7/23/19 at about 9:45 AM, my arm was hurting. Within about 3 hours I started to feel weak and tired, then the muscle aches over entire body began. Headache, stomach ache and backache were flu like. Body chills severe by 9 PM  and nausea by 4 AM the next morning.  All the symptoms described above continued into the next day. At about 7 PM on 7/24/19, I was feeling about seventy five percent better. On 7/25/19 diarrhea began in the morning by Noon it had cleared.
a reaction; rash on the arm (injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (a reaction) and INJECTION SITE RASH (rash on the arm (injection site)) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE RASH (rash on the arm (injection site)). On an unknown date, the patient experienced VACCINATION SITE REACTION (a reaction). At the time of the report, VACCINATION SITE REACTION (a reaction) outcome was unknown and INJECTION SITE RASH (rash on the arm (injection site)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2021: No specific follow-up information recorded.
This spontaneous case reported by a pharmacist, describes the occurrence of administered expired vaccine in a 64-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 031B21A) for COVID-19 immunization. No medical history reported. On Nov 11, 2021, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Nov 11, 2021, patient administered expired vaccine). On Nov 11, 2021, administered expired vaccine resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information.
This non-valid spontaneous report as received from a licensed practical nurse and a director refers to an unspecified number of patients of unknown ages and genders. No information was provided regarding the patients' concomitant medications, pertinent medical history, drug reactions or allergies. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (exact dose, dose number, route of administration were not reported; lot # N003703 with the expiration date of 29-OCT-2019) for prophylaxis. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (exact dose, dose number, route of administration were not reported; lot # N029303 with the expiration date of 21-APR-2019) for prophylaxis. No adverse effects were reported. The administered doses of vaccines underwent a temperature excursion between 32 Fahrenheit degrees (°F) and 35°F for 87 hours (also reported as "slightly out of range (34°F)"). The reporter stated that she went through all the proper reporting channels and was advised that the vaccines were still stable, since it was only 2°F outside the normal range (36-46°F). There were no previous temperature excursions reported. Digital data logger was involved to capture the temperature excursion. Product quality complaint (PQC) was not filed. Follow-up has been received on 29-JAN-2018. On unknown date, the patients were also vaccinated with improperly stored doses of PNEUMOVAX 23 (exact dose, dose number, route of administration were not reported; lot # N025656 with the expiration date of 19-APR-2019). Reporter stated that, fridge temperature was dropped to 34°F at some point over night and contacted to manufacturer to determine if product was still viable and confirmed that the product was good and nothing needed to disposed of. Patient did not experience any adverse events and was not administered with immunization before stability was confirmed. It was reported that this adverse experience was previously reported to manufacturer and temperature excursion as a result of a reading from a digital data logger.
Severe migraines for 4 days. Last two day could not get out of bed. Vomiting and could not eat. Then 2 days of lower grade headaches. This has been followed with some  hallucinations at night just before bedtime.
Less than 24 hours later my upper arm started to ache. It aches all the time day and night. This has been going on for 2 months now. No other symptoms. I did consult an ER MD.
developed PVC's - premature ventricular contractions.; use wife's cardiac device, and, never had an abnormal EKG before; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 19Mar2021 at 17:00 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included patient likely had COVID-19 during the week of 14Feb2021 and hematologist was sure the patient had it, in retrospect. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the right arm on 12Febr2021 at 16:30 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 08:00, the 4th day after the second dose the patient developed PVC's - premature ventricular contractions. The patient never had this before. In fact the patient  also used his wife's cardiac device and never had an abnormal EKG before. This included his annual check-up with physicians as well. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient underwent COVID-19 viral test (Nasal Swab) and the result was negative. The clinical outcome of the event  PVC's - premature ventricular contractions and abnormal EKG was recovering at the time of this report.
Day 8-red, raised, sore , hot, itchy 3in x3in bump at injection site. Ringing in left ear, extreme dizziness, headache, diarrhea, nausea and vomiting. Swollen tongue. Today is day  14- faded outline of big red area on arm, ringing in ears, dizziness and nausea, headaches.
After receiving his vaccine, pharmacist advised for the patient to sit down in a chair for 15 minutes for observation.   5 minutes after receiving his 2nd Moderna vaccine, the patient passed out in the chair for approximately 5-10 seconds.  It was observed by our employee that he made a gurgling sound and a weird body movement, similar to a seizure. His eyes were closed and his body is sluggish on the chair.  He was able to open his eyes back up and realized what happened. He was conscious, alert, and able to answer any questions after the event.
flu-like symptoms; very drowsy; chills; very tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), SOMNOLENCE (very drowsy), CHILLS (chills) and FATIGUE (very tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 013M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021 at 9:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), SOMNOLENCE (very drowsy), CHILLS (chills) and FATIGUE (very tired). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), SOMNOLENCE (very drowsy), CHILLS (chills) and FATIGUE (very tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported.   Patients symptoms started 12 hours after the booster dose administration and stated his symptoms are cleared up at the time of this report.  No treatment drug details was reported.   This case was linked to MOD-2021-395665, MOD-2021-395666 (Patient Link).
Redness, swelling, itching, warm to touch, firm. 6/13/03 T 99.6.
11 day mark on first Dose1, rash showed up, growing in dimension size and warm to the touch went prescribed a  topical cream, Blood pressure was high got the medication and applied then discovered the warming for high blood pressure user to not to use so wiped it.  lasted 4-5 days red outline it did not spread much beyond the marking they traced.
Information has been received from a 55 year old registered nurse female with allergy to codeine and sensitivity to peroxide such as in hair dye, and a history of swelling, redness, pain at the injection site with a typhoid vaccine (unspecified) who on 28-OCT-1998 was vaccinated with PNEUMOVAX 23 (lot # not reported). Concomitant therapy received on the same date included influenza virus vaccine (unspecified). It was reported that on 28-OCT-1998 the injection site was red and painful. On approximately 31-OCT-1998, "about 3-4 days after the vaccination" her left arm began to well from the injection site to the elbow. The swelling radiated from the left arm, across her chest and up into her throat. The arm developed a large liquid filled blister. The symptoms resolved in "two weeks", on approximately 11-NOV-1998. She mentioned that she had a similar reaction to at typhoid vaccine (unspecified) that she received in 1964 upon entering nursing school. The patient did not seek medical attention. Additional information has been requested.